Do you have the same question? Follow this Question
Jan 17, 2025 - 02:58 PM
We’ve provided several answers to questions related to Wixela (Fluticasone / Salmeterol) , see some other helpful Q&A related to this product.
Question: When is the best time to take Wixela?
Answer:
Question: What are the long term side effects of Wixela?
Answer:
Question: What is the MedlinePlus code for this product?
Answer: The MedlinePlus code is a699063. This resource offers patients and providers access to reliable health information, enhancing patient education and engagement.
Question: What is the PubChem CID for Fluticasone in this product?
Answer: The PubChem CID for Fluticasone is 5311101. This reference allows for quick access to chemical information and research studies, which can be valuable for further scientific investigation.
Question: What is the DrugBank ID for Salmeterol in this product?
Answer: The DrugBank ID for Salmeterol is DB00938. This helps healthcare professionals access comprehensive data about the drug for better understanding and management of treatment.
Question: What are some common side effects of this medication?
Answer: Common side effects include headaches, throat irritation, coughing, feelings of nausea, and voice changes. Awareness of these potential side effects allows patients to manage them effectively and seek medical advice if they become bothersome.
Question: What are the routes of administration for this product?
Answer: The route of administration is inhalation. This method allows the medication to directly target the lungs, providing rapid relief and minimizing systemic side effects.
Question: What is the protein binding percentage for Salmeterol in this product?
Answer: Salmeterol has a protein binding of 96%. This ensures prolonged action of the bronchodilator effect, making it effective for long-term management of breathing difficulties.
Question: What is the bioavailability of Fluticasone in this product?
Answer: The bioavailability of Fluticasone is 1%. This low bioavailability means that only a small fraction of the drug reaches systemic circulation, which is beneficial in minimizing systemic side effects while effectively targeting airway inflammation.
Question: What is the elimination half-life of this medication?
Answer: The elimination half-life is between 5.5 to 7.8 hours. This indicates how long the medication stays active in the body, which is important for managing dosing schedules and understanding how the drug will perform over time.
Question: What is the formula for Fluticasone in this product?
Answer: The formula for Fluticasone is C22H27F3O4S. This specific molecular composition enables the medication to effectively reduce airway inflammation, providing relief for asthma and COPD symptoms.
View all Wixela (Fluticasone / Salmeterol) Questions & Answers
